Research ExplorerJournalsCANCER INVEST Publications

CANCER INVEST - Cancer investigation

1 - 4 out of 4Page size: 50

Publications

  1. 2021

  2. Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer Aggressiveness

    Weidemann, S., Perez, D., Izbicki, J. R., Neipp, M., Mofid, H., Daniels, T., Nahrstedt, U., Jacobsen, F., Bernreuther, C., Simon, R., Steurer, S., Burandt, E., Marx, A. H., Krech, T., Clauditz, T. S. & Jansen, K., 10.2021, In: CANCER INVEST. 39, 9, p. 711-720 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. 2010

  4. Optimizing the use of sunitinib in metastatic renal cell carcinoma: an update from clinical practice.

    Schmidinger, M., Arnold, D., Szczylik, C., Wagstaff, J. & Ravaud, A., 2010, In: CANCER INVEST. 28, 8, p. 856-864 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. 2009

  6. Sodium Butyrate Increases Expression of the Coxsackie and Adenovirus Receptor in Colon Cancer Cells.

    Küster, K., Grötzinger, C., Koschel, A., Fischer, A., Wiedenmann, B. & Anders, M., 2009, In: CANCER INVEST.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. 2008

  8. Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines.

    Parsch, D., Brassat, U., Brümmendorf, T. & Fellenberg, J., 2008, In: CANCER INVEST. 26, 6, p. 590-596 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review